All Stories

Cancer vaccine prevents recurrence of advanced kidney cancer in small trial

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to an experimental, personalized cancer vaccine, researchers reported Feb. 5.

Feb 9, 2025 - 22:25
 0
Cancer vaccine prevents recurrence of advanced kidney cancer in small trial
After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to an experimental, personalized cancer vaccine, researchers reported Feb. 5.
Read More

Tags:

Previous Article

CF-focused Sionna goes public in $135M IPO, while Aardvark plots $103M listing

Next Article

Pfizer builds out oncology team with appointment of Novartis vet Jeff Legos

Related Posts

Boston Scientific clocks over $1B in Farapulse revenue for the afib therapy's first year

Boston Scientific clocks over $1B in Farapulse revenue ...

Feb 9, 2025  0

J&J MedTech restarts Varipulse's US rollout after stroke reports

J&J MedTech restarts Varipulse's US rollout after strok...

Feb 18, 2025  0

Repare unveils scale of layoffs with 75% of staff and chief medical officer heading for exit

Repare unveils scale of layoffs with 75% of staff and c...

Feb 25, 2025  0